FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET

FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET was reported 2112 times

FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD BICARBONATE 1 0.1111
1 FACIAL LESION EXCISION 1 0.1111
2 BILE CULTURE POSITIVE 1 0.0769
3 REMOVAL OF INERT MATTER FROM SKIN OR SUBCUTANEOUS TISSUE 1 0.0667
4 LINITIS PLASTICA 1 0.0588
5 ENDOMETRIAL METAPLASIA 1 0.0526
6 ETHMOID SINUS SURGERY 1 0.0435
7 METHYLENETETRAHYDROFOLATE REDUCTASE GENE MUTATION 2 0.0417
8 SINUS ANTROSTOMY 1 0.0400
9 SECONDARY SEQUESTRUM 1 0.0357
10 TICK-BORNE FEVER 2 0.0299
11 SUCROSE INTOLERANCE 1 0.0294
12 FAILURE OF CHILD RESISTANT PRODUCT CLOSURE 4 0.0290
13 EPIPHYSEAL FRACTURE 1 0.0250
14 HYDROCELE OPERATION 1 0.0233
15 ACCIDENTAL DRUG INTAKE BY CHILD 34 0.0221
16 MYRINGOTOMY 1 0.0185
17 MODIFIED RADICAL MASTECTOMY 1 0.0172
18 RENAL GLYCOSURIA 1 0.0147
19 HYPERGLOBULINAEMIA 1 0.0135
20 BIOPSY BREAST ABNORMAL 1 0.0105
21 TINEA CAPITIS 1 0.0087
22 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 1 0.0080
23 CYSTATIN C INCREASED 1 0.0078
24 CONTRAINDICATED DRUG ADMINISTERED 5 0.0071
25 END STAGE RENAL DISEASE 121 0.0066
26 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
27 BONE HYPERTROPHY 1 0.0062
28 RENAL ARTERY STENT PLACEMENT 1 0.0062
29 PHLEBOLITH 1 0.0059
30 BONE ATROPHY 1 0.0059
31 PELVIC FLOOR MUSCLE WEAKNESS 1 0.0058
32 CHRONIC KIDNEY DISEASE 443 0.0058
33 PH URINE INCREASED 1 0.0058
34 REBOUND ACID HYPERSECRETION 17 0.0056
35 TABLET PHYSICAL ISSUE 1 0.0055
36 CAROTID BRUIT 2 0.0052
37 CORTISOL ABNORMAL 1 0.0050
38 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 34 0.0050
39 NEPHROGENIC ANAEMIA 23 0.0050
40 PRODUCT PACKAGE ASSOCIATED INJURY 11 0.0049
41 HERNIA HIATUS REPAIR 1 0.0049
42 PHARMACEUTICAL PRODUCT COUNTERFEIT 1 0.0048
43 PRODUCT ADVERTISING ISSUE 1 0.0047
44 ILIOTIBIAL BAND SYNDROME 1 0.0044
45 PELVI-URETERIC OBSTRUCTION 1 0.0043
46 PRODUCT PHYSICAL ISSUE 83 0.0041
47 INTESTINAL MALROTATION 1 0.0038
48 CUTIS LAXA 1 0.0037
49 OESTROGEN DEFICIENCY 1 0.0036
50 HYPERPARATHYROIDISM SECONDARY 9 0.0036
51 MONARTHRITIS 1 0.0033
52 SUBDURAL HYGROMA 1 0.0033
53 FEAR OF EATING 1 0.0032
54 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
55 CATHETER SITE IRRITATION 1 0.0030
56 SALIVA DISCOLOURATION 1 0.0030
57 DIALYSIS RELATED COMPLICATION 1 0.0028
58 BIPOLAR II DISORDER 1 0.0028
59 PERIODIC LIMB MOVEMENT DISORDER 1 0.0027
60 BREAST RECONSTRUCTION 1 0.0027
61 CONTRAINDICATION TO MEDICAL TREATMENT 4 0.0026
62 MYASTHENIC SYNDROME 2 0.0026
63 SKIN TURGOR DECREASED 1 0.0026
64 THERAPEUTIC RESPONSE DELAYED 7 0.0025
65 BARRETT'S OESOPHAGUS 2 0.0025
66 POOR QUALITY PRODUCT ADMINISTERED 26 0.0025
67 INFUSION SITE WARMTH 3 0.0024
68 TONGUE ERYTHEMA 2 0.0024
69 PRODUCT CONTAINER SEAL ISSUE 4 0.0023
70 RENAL INJURY 67 0.0023
71 PRODUCT PACKAGING ISSUE 21 0.0022
72 CERUMEN IMPACTION 2 0.0022
73 REACTION TO EXCIPIENT 5 0.0022
74 SICKLE CELL DISEASE 1 0.0022
75 ADENOCARCINOMA GASTRIC 2 0.0022
76 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
77 ARTIFICIAL CROWN PROCEDURE 1 0.0020
78 HYPERCALCIURIA 1 0.0020
79 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
80 THERAPEUTIC RESPONSE UNEXPECTED 89 0.0020
81 SUSPECTED PRODUCT CONTAMINATION 2 0.0020
82 TUBULOINTERSTITIAL NEPHRITIS 37 0.0020
83 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
84 URETEROLITHIASIS 2 0.0019
85 PRODUCT COMMINGLING 2 0.0019
86 HYPERTENSIVE NEPHROPATHY 2 0.0019
87 PRODUCT TASTE ABNORMAL 25 0.0018
88 INFUSION SITE MASS 2 0.0018
89 DRUG EXPOSURE VIA BREAST MILK 2 0.0018
90 SEBORRHOEIC DERMATITIS 3 0.0018
91 PRODUCT CLOSURE ISSUE 1 0.0018
92 LUNG INFECTION PSEUDOMONAL 1 0.0018
93 BONE FRAGMENTATION 1 0.0018
94 SUSPECTED PRODUCT TAMPERING 1 0.0018
95 BUNION OPERATION 1 0.0018
96 PRODUCT LABEL ISSUE 12 0.0018
97 NAIL BED BLEEDING 1 0.0018
98 SALPINGECTOMY 1 0.0017
99 ENTERAL NUTRITION 1 0.0017
100 AORTIC CALCIFICATION 1 0.0017
101 NEPHROPATHY 16 0.0017
102 DEVICE MAINTENANCE ISSUE 1 0.0017
103 PRODUCT FORMULATION ISSUE 11 0.0017
104 PROCTITIS ULCERATIVE 1 0.0017
105 OTITIS EXTERNA 2 0.0016
106 SPONTANEOUS PENILE ERECTION 1 0.0016
107 ACUTE KIDNEY INJURY 238 0.0016
108 GASTROOESOPHAGEAL REFLUX DISEASE 121 0.0015
109 CATARACT NUCLEAR 1 0.0015
110 URETHRAL STENOSIS 1 0.0015
111 OPHTHALMIC MIGRAINE 1 0.0014
112 THERAPEUTIC PROCEDURE 2 0.0014
113 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
114 DERMATITIS DIAPER 1 0.0014
115 PARASOMNIA 1 0.0014
116 GRANULOMA ANNULARE 1 0.0014
117 STOMA SITE PAIN 2 0.0014
118 CENTRAL OBESITY 1 0.0014
119 AMINO ACID LEVEL INCREASED 1 0.0013
120 ACCIDENTAL OVERDOSE 49 0.0013
121 ASPIRATION PLEURAL CAVITY 1 0.0013
122 REACTION TO PRESERVATIVES 1 0.0012
123 GASTRIC CANCER STAGE III 1 0.0012
124 ERECTION INCREASED 5 0.0012
125 ACUTE SINUSITIS 2 0.0012
126 RENAL FAILURE 151 0.0011
127 PRODUCT TAMPERING 2 0.0011
128 SELECTIVE EATING DISORDER 1 0.0011
129 OESOPHAGEAL SPASM 2 0.0011
130 BIOPSY 1 0.0011
131 PHARYNGEAL HYPOAESTHESIA 1 0.0011
132 PROGESTERONE RECEPTOR ASSAY POSITIVE 1 0.0011
133 PSYCHOGENIC SEIZURE 1 0.0011
134 BONE CYST 1 0.0011
135 NARCOLEPSY 2 0.0011
136 PRODUCT SHAPE ISSUE 1 0.0011
137 GUN SHOT WOUND 2 0.0011
138 ULNA FRACTURE 1 0.0010
139 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
140 GASTRECTOMY 1 0.0010
141 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
142 RENAL MASS 2 0.0010
143 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
144 THYROID HORMONES INCREASED 1 0.0010
145 EXPOSURE DURING PREGNANCY 59 0.0009
146 TONGUE DISCOMFORT 4 0.0009
147 HYDROCELE 1 0.0009
148 INFUSION SITE BRUISING 2 0.0009
149 KIDNEY ENLARGEMENT 1 0.0009
150 PILOERECTION 1 0.0009
151 SOFT TISSUE DISORDER 1 0.0009
152 DYSGEUSIA 67 0.0009
153 NEPHROSCLEROSIS 1 0.0009
154 PRODUCT LOT NUMBER ISSUE 2 0.0009
155 DRUG EFFECT VARIABLE 1 0.0009
156 OESTROGEN RECEPTOR ASSAY POSITIVE 1 0.0009
157 MOANING 1 0.0009
158 UTERINE DISORDER 2 0.0009
159 TONGUE HAEMORRHAGE 1 0.0009
160 INTRUSIVE THOUGHTS 1 0.0008
161 NEPHROCALCINOSIS 1 0.0008
162 POST-ACUTE COVID-19 SYNDROME 1 0.0008
163 PALATAL OEDEMA 1 0.0008
164 HYPERAESTHESIA TEETH 1 0.0008
165 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
166 GLUCOSE URINE PRESENT 1 0.0008
167 APPLICATION SITE WARMTH 1 0.0008
168 PRODUCT COLOUR ISSUE 4 0.0008
169 CALCIUM DEFICIENCY 1 0.0008
170 PRODUCT ODOUR ABNORMAL 8 0.0008
171 OESOPHAGEAL HAEMORRHAGE 1 0.0008
172 WHITE BLOOD CELL DISORDER 2 0.0007
173 INCORRECT DRUG ADMINISTRATION DURATION 21 0.0007
174 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
175 TRIGGER FINGER 3 0.0007
176 CORNEAL ABRASION 1 0.0007
177 RENAL ARTERY STENOSIS 1 0.0007
178 APPLICATION SITE INFLAMMATION 1 0.0007
179 DRUG EFFECT INCOMPLETE 26 0.0007
180 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
181 CULTURE URINE POSITIVE 1 0.0007
182 PRECANCEROUS CELLS PRESENT 1 0.0007
183 SEBORRHOEIC KERATOSIS 1 0.0007
184 ONYCHOMYCOSIS 3 0.0007
185 GENERALISED ANXIETY DISORDER 1 0.0007
186 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
187 NEPHRECTOMY 1 0.0007
188 ATYPICAL PNEUMONIA 2 0.0007
189 HYPOAESTHESIA FACIAL 1 0.0007
190 EPICONDYLITIS 1 0.0007
191 MOUTH INJURY 1 0.0007
192 PNEUMONIA PSEUDOMONAL 1 0.0007
193 EXPIRED PRODUCT ADMINISTERED 21 0.0006
194 INTERMITTENT CLAUDICATION 1 0.0006
195 PHARYNGEAL PARAESTHESIA 1 0.0006
196 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
197 DYSPEPSIA 61 0.0006
198 POOR QUALITY DRUG ADMINISTERED 4 0.0006
199 COSTOCHONDRITIS 1 0.0006
200 RENAL TUBULAR NECROSIS 6 0.0006
201 INFUSION SITE HAEMORRHAGE 2 0.0006
202 INCORRECT PRODUCT ADMINISTRATION DURATION 13 0.0006
203 LYME DISEASE 2 0.0006
204 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
205 GASTRIC DILATATION 1 0.0006
206 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
207 WRONG PRODUCT ADMINISTERED 4 0.0006
208 CLOSTRIDIAL INFECTION 2 0.0006
209 EROSIVE OESOPHAGITIS 1 0.0006
210 CERVICAL SPINAL STENOSIS 1 0.0006
211 TONGUE COATED 1 0.0006
212 RECALLED PRODUCT 1 0.0006
213 ORAL DISCOMFORT 8 0.0006
214 BURNS SECOND DEGREE 1 0.0006
215 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
216 PRODUCT CONTAMINATION 2 0.0006
217 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
218 TONGUE DISORDER 4 0.0006
219 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
220 ESSENTIAL HYPERTENSION 1 0.0005
221 LUPUS NEPHRITIS 1 0.0005
222 CHRONIC SINUSITIS 2 0.0005
223 COMMUNICATION DISORDER 2 0.0005
224 RETCHING 11 0.0005
225 VITAMIN D DEFICIENCY 5 0.0005
226 MULTI-ORGAN DISORDER 1 0.0005
227 OESOPHAGEAL PAIN 2 0.0005
228 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
229 JOINT CREPITATION 1 0.0005
230 VITAMIN B12 DEFICIENCY 2 0.0005
231 LIBIDO INCREASED 1 0.0005
232 PERIPHERAL VENOUS DISEASE 2 0.0005
233 TONGUE BITING 1 0.0005
234 CHEST INJURY 1 0.0005
235 URINARY BLADDER HAEMORRHAGE 1 0.0005
236 INFUSION SITE ERYTHEMA 4 0.0005
237 DEVICE CONNECTION ISSUE 1 0.0005
238 ABSCESS LIMB 2 0.0005
239 REACTION TO DRUG EXCIPIENTS 1 0.0005
240 GASTRIC BYPASS 1 0.0005
241 TONGUE DISCOLOURATION 2 0.0005
242 PARONYCHIA 2 0.0005
243 DIABETIC NEPHROPATHY 1 0.0005
244 COLONOSCOPY 1 0.0005
245 CLOSTRIDIUM TEST POSITIVE 1 0.0005
246 RHINITIS ALLERGIC 2 0.0004
247 TEMPERATURE REGULATION DISORDER 1 0.0004
248 TONGUE BLISTERING 1 0.0004
249 FEAR OF DEATH 1 0.0004
250 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
251 CHRONIC GASTRITIS 1 0.0004
252 RENAL COLIC 1 0.0004
253 DRUG EFFECT DELAYED 2 0.0004
254 HAEMOGLOBIN INCREASED 2 0.0004
255 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
256 APHTHOUS STOMATITIS 1 0.0004
257 HAEMANGIOMA 1 0.0004
258 RENAL FUNCTION TEST ABNORMAL 2 0.0004
259 LACERATION 4 0.0004
260 SINUS OPERATION 1 0.0004
261 RADIUS FRACTURE 1 0.0004
262 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 84 0.0004
263 BRONCHITIS CHRONIC 1 0.0004
264 NASAL POLYPS 2 0.0004
265 HYPERVOLAEMIA 2 0.0004
266 DEVICE INFUSION ISSUE 1 0.0004
267 PRODUCT USE IN UNAPPROVED INDICATION 99 0.0004
268 DIABETIC COMPLICATION 1 0.0004
269 HEPATOSPLENOMEGALY 1 0.0004
270 AORTIC ARTERIOSCLEROSIS 1 0.0004
271 VARICOSE VEIN 2 0.0004
272 HIATUS HERNIA 5 0.0004
273 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
274 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
275 RENAL CYST 3 0.0004
276 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
277 INCORRECT DOSE ADMINISTERED 85 0.0004
278 PRODUCT SIZE ISSUE 2 0.0004
279 FAECES DISCOLOURED 8 0.0004
280 ACCIDENTAL EXPOSURE TO PRODUCT 38 0.0004
281 LIP BLISTER 1 0.0004
282 RHINALGIA 1 0.0004
283 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
284 NERVE INJURY 4 0.0004
285 RESPIRATORY SYMPTOM 1 0.0004
286 PANCREATIC CARCINOMA METASTATIC 1 0.0004
287 OESOPHAGEAL STENOSIS 1 0.0004
288 HAEMOTHORAX 1 0.0003
289 NAIL DISORDER 3 0.0003
290 TOOTH DISCOLOURATION 1 0.0003
291 BLOOD CULTURE POSITIVE 1 0.0003
292 CRANIOCEREBRAL INJURY 1 0.0003
293 IRON DEFICIENCY ANAEMIA 3 0.0003
294 PRE-EXISTING CONDITION IMPROVED 2 0.0003
295 PRODUCT USE ISSUE 60 0.0003
296 ARTERIOSCLEROSIS 3 0.0003
297 SWELLING OF EYELID 2 0.0003
298 INFUSION SITE SWELLING 2 0.0003
299 INFUSION SITE PRURITUS 1 0.0003
300 DRUG EFFECT INCREASED 1 0.0003
301 TESTICULAR PAIN 1 0.0003
302 PNEUMONIA VIRAL 1 0.0003
303 GLOSSODYNIA 7 0.0003
304 CARDIAC FLUTTER 2 0.0003
305 ANGINA UNSTABLE 2 0.0003
306 POSTURE ABNORMAL 1 0.0003
307 LISTLESS 1 0.0003
308 WALKING AID USER 2 0.0003
309 SALIVARY HYPERSECRETION 3 0.0003
310 DRY THROAT 3 0.0003
311 SUBARACHNOID HAEMORRHAGE 3 0.0003
312 IMPAIRED GASTRIC EMPTYING 4 0.0003
313 REGURGITATION 1 0.0003
314 TACHYPHRENIA 1 0.0003
315 DEFAECATION URGENCY 2 0.0003
316 NEPHROLITHIASIS 13 0.0003
317 DIALYSIS 4 0.0003
318 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
319 BODY HEIGHT DECREASED 3 0.0003
320 RENAL TRANSPLANT 1 0.0003
321 SPONDYLITIS 1 0.0003
322 FAECES SOFT 2 0.0003
323 BONE DISORDER 5 0.0003
324 OVERDOSE 59 0.0003
325 PROTEIN TOTAL DECREASED 1 0.0003
326 SNORING 1 0.0003
327 MICTURITION URGENCY 3 0.0003
328 PARANASAL SINUS HYPERSECRETION 1 0.0003
329 DRUG DISPENSING ERROR 4 0.0003
330 GASTRIC INFECTION 1 0.0003
331 BOWEL MOVEMENT IRREGULARITY 2 0.0003
332 THYROID MASS 1 0.0003
333 MUSCULOSKELETAL CHEST PAIN 4 0.0003
334 ERUCTATION 5 0.0003
335 REHABILITATION THERAPY 1 0.0003
336 PANIC DISORDER 1 0.0003
337 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
338 FAECES HARD 1 0.0003
339 MUSCLE RUPTURE 1 0.0003
340 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
341 SKIN ODOUR ABNORMAL 1 0.0003
342 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
343 NASAL DISCOMFORT 2 0.0003
344 WRIST FRACTURE 3 0.0003
345 BLEPHARITIS 1 0.0002
346 INTRACRANIAL ANEURYSM 1 0.0002
347 NOCTURIA 3 0.0002
348 SPINAL FUSION SURGERY 1 0.0002
349 POLYURIA 2 0.0002
350 GOITRE 1 0.0002
351 ANAPHYLACTOID REACTION 1 0.0002
352 SENSATION OF FOREIGN BODY 2 0.0002
353 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
354 INTERVERTEBRAL DISC DISORDER 1 0.0002
355 LUNG NEOPLASM 1 0.0002
356 SHOULDER OPERATION 1 0.0002
357 PRODUCT DISPENSING ISSUE 1 0.0002
358 SCAR 4 0.0002
359 INFUSION SITE PAIN 3 0.0002
360 CARDIAC MURMUR 2 0.0002
361 HORDEOLUM 1 0.0002
362 THERAPEUTIC RESPONSE DECREASED 14 0.0002
363 OCULAR ICTERUS 1 0.0002
364 CHAPPED LIPS 1 0.0002
365 TOOTH INJURY 1 0.0002
366 MELANOCYTIC NAEVUS 1 0.0002
367 DYSPHEMIA 1 0.0002
368 SPINAL OSTEOARTHRITIS 2 0.0002
369 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
370 BLOOD CREATINE INCREASED 1 0.0002
371 EXTRA DOSE ADMINISTERED 9 0.0002
372 SINUS CONGESTION 3 0.0002
373 PAPILLOEDEMA 1 0.0002
374 OROPHARYNGEAL DISCOMFORT 2 0.0002
375 ABDOMINAL DISCOMFORT 37 0.0002
376 LIP DRY 2 0.0002
377 OPTIC NEURITIS 2 0.0002
378 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
379 EAR DISORDER 1 0.0002
380 NERVE COMPRESSION 2 0.0002
381 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
382 RENAL IMPAIRMENT 18 0.0002
383 FLANK PAIN 2 0.0002
384 SKIN TIGHTNESS 1 0.0002
385 SEASONAL ALLERGY 3 0.0002
386 PULSE ABSENT 1 0.0002
387 MEDICATION RESIDUE PRESENT 1 0.0002
388 IMPAIRED QUALITY OF LIFE 3 0.0002
389 DRUG PRESCRIBING ERROR 4 0.0002
390 PARAESTHESIA ORAL 3 0.0002
391 SINUS BRADYCARDIA 2 0.0002
392 PRESCRIBED OVERDOSE 4 0.0002
393 INCORRECT DOSAGE ADMINISTERED 1 0.0002
394 PHARYNGEAL SWELLING 2 0.0002
395 GASTRIC DISORDER 7 0.0002
396 SINUS DISORDER 4 0.0002
397 MUCOUS STOOLS 1 0.0002
398 BLADDER DISORDER 2 0.0002
399 ABDOMINAL TENDERNESS 1 0.0002
400 ANEURYSM 1 0.0002
401 INJECTION SITE INFLAMMATION 1 0.0002
402 PROTEIN URINE PRESENT 1 0.0002
403 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
404 HYPOAESTHESIA ORAL 3 0.0002
405 CORONARY ARTERY DISEASE 6 0.0002
406 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
407 PRODUCT ADMINISTRATION ERROR 4 0.0002
408 GASTRIC CANCER 5 0.0002
409 EYELID PTOSIS 2 0.0002
410 PHLEBITIS 1 0.0002
411 PHARYNGEAL OEDEMA 3 0.0002
412 INCREASED UPPER AIRWAY SECRETION 1 0.0002
413 PERIORBITAL OEDEMA 1 0.0002
414 APLASTIC ANAEMIA 1 0.0002
415 WEIGHT FLUCTUATION 2 0.0002
416 PARTIAL SEIZURES 1 0.0002
417 DYSURIA 7 0.0002
418 FOOD CRAVING 1 0.0002
419 GASTRITIS 5 0.0002
420 INCONTINENCE 2 0.0002
421 SCIATICA 3 0.0002
422 PHARYNGOLARYNGEAL PAIN 1 0.0002
423 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
424 PRODUCT RESIDUE PRESENT 1 0.0002
425 STRESS FRACTURE 1 0.0002
426 BLOOD POTASSIUM INCREASED 3 0.0002
427 TIC 1 0.0002
428 JAW DISORDER 1 0.0002
429 TOOTH FRACTURE 2 0.0002
430 DENTAL CARIES 2 0.0002
431 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
432 GASTRIC ULCER HAEMORRHAGE 1 0.0002
433 DEPRESSION 41 0.0002
434 INTERMENSTRUAL BLEEDING 1 0.0002
435 THROAT IRRITATION 8 0.0002
436 HEART RATE IRREGULAR 4 0.0002
437 PERIORBITAL SWELLING 1 0.0002
438 CHOLECYSTITIS ACUTE 1 0.0002
439 DRUG INEFFECTIVE 232 0.0002
440 DERMATITIS CONTACT 2 0.0002
441 HAEMATURIA 6 0.0002
442 ABDOMINAL PAIN UPPER 36 0.0002
443 ADVERSE EVENT 16 0.0002
444 RHEUMATOID FACTOR POSITIVE 1 0.0002
445 MADAROSIS 2 0.0002
446 HYPERTRIGLYCERIDAEMIA 1 0.0002
447 HYPERCHLORHYDRIA 1 0.0002
448 HEAD DISCOMFORT 3 0.0002
449 ATAXIA 2 0.0002
450 MACULAR DEGENERATION 2 0.0002
451 HYPERLIPIDAEMIA 2 0.0002
452 DRUG EFFECT DECREASED 9 0.0002
453 HEARING IMPAIRED 1 0.0002
454 INJECTION SITE VESICLES 1 0.0002
455 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
456 TENDON RUPTURE 2 0.0002
457 PIGMENTATION DISORDER 1 0.0002
458 SCOLIOSIS 1 0.0002
459 CHOLANGITIS 1 0.0002
460 INFUSION SITE EXTRAVASATION 1 0.0002
461 PNEUMONIA ASPIRATION 4 0.0002
462 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
463 PHOTOPSIA 1 0.0002
464 BLOOD URINE PRESENT 3 0.0002
465 FEELING JITTERY 3 0.0002
466 DIABETES MELLITUS 12 0.0002
467 CYSTITIS 5 0.0002
468 INTRAOCULAR PRESSURE INCREASED 2 0.0002
469 ROTATOR CUFF SYNDROME 2 0.0002
470 APPLICATION SITE VESICLES 1 0.0002
471 RESPIRATORY TRACT INFECTION 4 0.0002
472 BRADYPHRENIA 1 0.0002
473 POLYP 1 0.0002
474 SOMNAMBULISM 1 0.0002
475 APPETITE DISORDER 1 0.0002
476 ADVERSE REACTION 2 0.0002
477 UPPER LIMB FRACTURE 3 0.0002
478 SPINAL FRACTURE 3 0.0001
479 HAIR TEXTURE ABNORMAL 2 0.0001
480 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
481 POST-TRAUMATIC STRESS DISORDER 1 0.0001
482 JOINT RANGE OF MOTION DECREASED 2 0.0001
483 BREAST MASS 1 0.0001
484 EYE PRURITUS 5 0.0001
485 INTENTIONAL PRODUCT MISUSE 13 0.0001
486 BRONCHIECTASIS 1 0.0001
487 ULCER HAEMORRHAGE 1 0.0001
488 PRODUCTIVE COUGH 7 0.0001
489 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
490 EYE MOVEMENT DISORDER 1 0.0001
491 NEPHROTIC SYNDROME 1 0.0001
492 PERIPHERAL COLDNESS 2 0.0001
493 ONYCHOCLASIS 1 0.0001
494 RESPIRATION ABNORMAL 1 0.0001
495 DROOLING 1 0.0001
496 LYMPHOEDEMA 1 0.0001
497 PULMONARY HYPERTENSION 3 0.0001
498 LARGE INTESTINE PERFORATION 1 0.0001
499 CARPAL TUNNEL SYNDROME 2 0.0001
500 BURNING SENSATION 10 0.0001
501 APPLICATION SITE REACTION 1 0.0001
502 HAND FRACTURE 1 0.0001
503 FLATULENCE 8 0.0001
504 PRODUCT QUALITY ISSUE 19 0.0001
505 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
506 CELLULITIS 7 0.0001
507 PANIC REACTION 1 0.0001
508 HYPOKINESIA 2 0.0001
509 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
510 MAJOR DEPRESSION 1 0.0001
511 MOUTH HAEMORRHAGE 1 0.0001
512 DRY MOUTH 11 0.0001
513 HYPOPHOSPHATAEMIA 1 0.0001
514 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
515 FEELING DRUNK 1 0.0001
516 COLON CANCER 2 0.0001
517 SUNBURN 1 0.0001
518 TENDON PAIN 1 0.0001
519 OSTEOPENIA 2 0.0001
520 TROPONIN INCREASED 1 0.0001
521 AORTIC ANEURYSM 1 0.0001
522 INSURANCE ISSUE 2 0.0001
523 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
524 DRUG ADMINISTRATION ERROR 4 0.0001
525 RENAL FAILURE CHRONIC 1 0.0001
526 THYROID DISORDER 2 0.0001
527 FOOD ALLERGY 1 0.0001
528 ANKLE FRACTURE 2 0.0001
529 RENAL DISORDER 6 0.0001
530 BASAL CELL CARCINOMA 2 0.0001
531 CHILLS 15 0.0001
532 BRAIN FOG 2 0.0001
533 ANXIETY 36 0.0001
534 RESPIRATORY TRACT CONGESTION 2 0.0001
535 HYPOTHYROIDISM 4 0.0001
536 NIGHT SWEATS 4 0.0001
537 STENT PLACEMENT 1 0.0001
538 FRUSTRATION TOLERANCE DECREASED 1 0.0001
539 MUSCLE DISORDER 1 0.0001
540 GASTROINTESTINAL DISORDER 11 0.0001
541 ABNORMAL FAECES 1 0.0001
542 OSTEOPOROSIS 5 0.0001
543 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
544 HAIR DISORDER 1 0.0001
545 STAPHYLOCOCCAL INFECTION 4 0.0001
546 SPINAL COMPRESSION FRACTURE 1 0.0001
547 EPISTAXIS 9 0.0001
548 DRY EYE 6 0.0001
549 GAIT INABILITY 4 0.0001
550 PALPITATIONS 14 0.0001
551 PRODUCT COMPLAINT 3 0.0001
552 SINUSITIS 12 0.0001
553 ERECTILE DYSFUNCTION 3 0.0001
554 PRODUCT CONTAINER ISSUE 1 0.0001
555 PSEUDOMONAS INFECTION 1 0.0001
556 ILLNESS 12 0.0001
557 DYSPHAGIA 11 0.0001
558 PSYCHOLOGICAL TRAUMA 1 0.0001
559 MUSCLE STRAIN 1 0.0001
560 PYELONEPHRITIS 1 0.0001
561 NERVOUSNESS 6 0.0001
562 DEAFNESS 3 0.0001
563 SYRINGE ISSUE 2 0.0001
564 BLOOD CALCIUM INCREASED 1 0.0001
565 GROIN PAIN 1 0.0001
566 TUMOUR LYSIS SYNDROME 1 0.0001
567 FACIAL PAIN 1 0.0001
568 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
569 HAEMOLYTIC ANAEMIA 1 0.0001
570 FEAR 3 0.0001
571 GOUT 2 0.0001
572 GASTROENTERITIS VIRAL 2 0.0001
573 OSTEOMYELITIS 2 0.0001
574 DIZZINESS 55 0.0001
575 PELVIC PAIN 2 0.0001
576 TREATMENT NONCOMPLIANCE 6 0.0001
577 HIDRADENITIS 1 0.0001
578 RETINAL DETACHMENT 1 0.0001
579 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
580 OROPHARYNGEAL PAIN 10 0.0001
581 CONJUNCTIVITIS 2 0.0001
582 APPENDICITIS 1 0.0001
583 DIARRHOEA HAEMORRHAGIC 1 0.0001
584 EYE PAIN 6 0.0001
585 PAIN IN JAW 3 0.0001
586 CONDITION AGGRAVATED 32 0.0001
587 GASTRIC ULCER 2 0.0001
588 PROTEINURIA 2 0.0001
589 RED BLOOD CELL COUNT DECREASED 3 0.0001
590 SLEEP APNOEA SYNDROME 2 0.0001
591 ANGINA PECTORIS 3 0.0001
592 INCREASED APPETITE 2 0.0001
593 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
594 HERPES ZOSTER 6 0.0001
595 ACUTE RESPIRATORY FAILURE 2 0.0001
596 ATELECTASIS 1 0.0001
597 DYSPHONIA 6 0.0001
598 HAEMORRHOIDS 2 0.0001
599 HEPATOMEGALY 1 0.0001
600 URINARY INCONTINENCE 3 0.0001
601 HOSPICE CARE 1 0.0001
602 DISORIENTATION 4 0.0001
603 CONSTIPATION 22 0.0001
604 BLOOD POTASSIUM DECREASED 3 0.0001
605 LACRIMATION INCREASED 3 0.0001
606 FULL BLOOD COUNT DECREASED 2 0.0001
607 PSORIATIC ARTHROPATHY 4 0.0001
608 SLUGGISHNESS 1 0.0001
609 EUPHORIC MOOD 1 0.0001
610 INITIAL INSOMNIA 1 0.0001
611 EAR DISCOMFORT 1 0.0001
612 RIB FRACTURE 2 0.0001
613 HYPERSENSITIVITY 18 0.0001
614 EYE DISCHARGE 1 0.0001
615 SWOLLEN TONGUE 3 0.0001
616 DIARRHOEA 62 0.0001
617 HEADACHE 60 0.0001
618 HEAD INJURY 3 0.0001
619 NEUROPATHY PERIPHERAL 9 0.0001
620 SOMNOLENCE 19 0.0001
621 MOOD SWINGS 3 0.0001
622 URINARY TRACT INFECTION 16 0.0001
623 HEREDITARY ANGIOEDEMA 1 0.0001
624 RECTAL HAEMORRHAGE 4 0.0001
625 PRURITUS GENERALISED 2 0.0001
626 PHARYNGITIS STREPTOCOCCAL 1 0.0001
627 SKIN LACERATION 1 0.0001
628 BACK INJURY 1 0.0001
629 CHEST PAIN 17 0.0001
630 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
631 BLOOD PRESSURE INCREASED 14 0.0001
632 OESOPHAGITIS 1 0.0001
633 HEART RATE INCREASED 9 0.0001
634 HAEMATOCHEZIA 5 0.0001
635 TREMOR 15 0.0001
636 FOOT DEFORMITY 1 0.0001
637 LIP SWELLING 3 0.0001
638 ORAL PAIN 2 0.0001
639 INTESTINAL PERFORATION 1 0.0001
640 OFF LABEL USE 78 0.0001
641 OCULAR DISCOMFORT 1 0.0001
642 FISTULA 1 0.0001
643 BLOOD CALCIUM DECREASED 1 0.0001
644 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
645 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
646 CHROMATURIA 2 0.0001
647 REBOUND EFFECT 1 0.0001
648 CHEST DISCOMFORT 9 0.0001
649 TINNITUS 4 0.0001
650 GASTRIC HAEMORRHAGE 1 0.0001
651 PRODUCT SUBSTITUTION ISSUE 5 0.0001
652 MUSCLE TWITCHING 2 0.0001
653 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
654 METASTASES TO LUNG 1 0.0001
655 PERICARDIAL EFFUSION 2 0.0001
656 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
657 ELECTROLYTE IMBALANCE 1 0.0001
658 HYPERHIDROSIS 11 0.0001
659 SPINAL PAIN 1 0.0001
660 SURGERY 5 0.0001
661 NASAL CONGESTION 5 0.0001
662 HYPERTENSION 18 0.0001
663 FEELING ABNORMAL 20 0.0001
664 THYROID CANCER 1 0.0001
665 VOMITING 39 0.0001
666 STOMATITIS 5 0.0001
667 NAUSEA 65 0.0001
668 RESTLESSNESS 3 0.0001
669 FEELING HOT 5 0.0001
670 BALANCE DISORDER 7 0.0001
671 ABASIA 2 0.0001
672 GENERALISED OEDEMA 1 0.0001
673 EYE SWELLING 3 0.0001
674 PHARYNGITIS 1 0.0001
675 CYST 1 0.0001
676 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
677 HAIR COLOUR CHANGES 1 0.0001
678 TOOTH EXTRACTION 1 0.0001
679 AGEUSIA 2 0.0001
680 SECRETION DISCHARGE 1 0.0001
681 COVID-19 14 0.0001
682 MUSCLE ATROPHY 1 0.0001
683 HAEMATEMESIS 2 0.0001
684 DEVICE DEPLOYMENT ISSUE 1 0.0001
685 SEIZURE 9 0.0001
686 SKIN ULCER 2 0.0001
687 INJECTION SITE INDURATION 1 0.0001
688 AMNESIA 5 0.0001
689 SWELLING FACE 5 0.0001
690 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
691 NODULE 1 0.0001
692 MUSCULOSKELETAL PAIN 4 0.0001
693 SPEECH DISORDER 4 0.0001
694 ARTHRITIS 6 0.0001
695 INCORRECT PRODUCT STORAGE 1 0.0001
696 BEDRIDDEN 1 0.0001
697 IMMUNE SYSTEM DISORDER 1 0.0001
698 TOOTH INFECTION 1 0.0001
699 MALIGNANT MELANOMA 1 0.0001
700 DISTURBANCE IN ATTENTION 4 0.0001
701 THROAT TIGHTNESS 2 0.0001
702 DYSKINESIA 3 0.0001
703 OEDEMA 4 0.0001
704 LIMB INJURY 2 0.0001
705 MIGRAINE 7 0.0001
706 GINGIVAL BLEEDING 1 0.0001
707 DEVICE MECHANICAL ISSUE 1 0.0001
708 CORONARY ARTERY OCCLUSION 1 0.0001
709 MEMORY IMPAIRMENT 10 0.0001
710 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
711 ATRIAL FIBRILLATION 7 0.0001
712 NECK PAIN 4 0.0001
713 DEMENTIA 2 0.0001
714 WOUND 2 0.0001
715 MASS 1 0.0001
716 BLISTER 4 0.0001
717 BLOOD TEST ABNORMAL 1 0.0001
718 INJURY 5 0.0001
719 SKIN REACTION 1 0.0001
720 BLINDNESS UNILATERAL 1 0.0001
721 MUSCULAR WEAKNESS 8 0.0001
722 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
723 PARAESTHESIA 11 0.0001
724 SUBDURAL HAEMATOMA 1 0.0001
725 HYPERSOMNIA 2 0.0001
726 HYPOACUSIS 3 0.0001
727 AGITATION 5 0.0001
728 INSOMNIA 18 0.0001
729 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
730 CATARACT 4 0.0001
731 PULMONARY MASS 1 0.0001
732 IMMUNODEFICIENCY 1 0.0001
733 ABDOMINAL DISTENSION 7 0.0001
734 ADVERSE DRUG REACTION 6 0.0001
735 FATIGUE 52 0.0001
736 SKIN DISCOLOURATION 3 0.0001
737 TENDONITIS 1 0.0001
738 DELUSION 1 0.0001
739 LUNG INFECTION 1 0.0001
740 BLOOD CHOLESTEROL INCREASED 3 0.0001
741 EJECTION FRACTION DECREASED 1 0.0001
742 BLOOD GLUCOSE INCREASED 12 0.0001
743 COMA 3 0.0001
744 OBESITY 1 0.0001
745 RASH ERYTHEMATOUS 3 0.0001
746 ABSCESS 1 0.0001
747 ARTHRALGIA 26 0.0001
748 BLOOD GLUCOSE DECREASED 3 0.0001
749 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
750 LOSS OF CONSCIOUSNESS 8 0.0001
751 INTENTIONAL OVERDOSE 4 0.0001
752 BACK DISORDER 1 0.0001
753 MULTIPLE FRACTURES 1 0.0001
754 MANIA 1 0.0001
755 INFUSION RELATED REACTION 4 0.0001
756 MUSCLE SPASMS 11 0.0001
757 BLOOD UREA INCREASED 1 0.0001
758 PERICARDITIS 1 0.0001
759 MALAISE 26 0.0001
760 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
761 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
762 PERIPHERAL SWELLING 9 0.0001
763 MUSCULOSKELETAL DISCOMFORT 1 0.0001
764 MULTI-ORGAN FAILURE 1 0.0001
765 WEIGHT DECREASED 16 0.0001
766 PRURITUS 22 0.0001
767 METASTASES TO LIVER 1 0.0001
768 COLD SWEAT 1 0.0001
769 ALOPECIA 11 0.0001
770 ABDOMINAL PAIN 13 0.0001
771 CONFUSIONAL STATE 9 0.0001
772 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
773 RESTLESS LEGS SYNDROME 1 0.0001
774 BLOOD GLUCOSE ABNORMAL 1 0.0001
775 SEPSIS 6 0.0001
776 HEPATIC STEATOSIS 1 0.0001
777 THINKING ABNORMAL 1 0.0001
778 BACTERIAL INFECTION 1 0.0001
779 MIDDLE INSOMNIA 1 0.0001
780 PHOTOPHOBIA 1 0.0001
781 ASTHMA 6 0.0001
782 MYALGIA 9 0.0001
783 FRACTURE 1 0.0001
784 FOOT FRACTURE 1 0.0001
785 EYE IRRITATION 3 0.0001
786 LOWER LIMB FRACTURE 1 0.0001
787 PYREXIA 18 0.0001
788 GLAUCOMA 1 0.0001
789 HERNIA 1 0.0001
790 EAR PAIN 1 0.0001
791 PLASMA CELL MYELOMA 2 0.0001
792 FALL 17 0.0001
793 PRODUCT DOSE OMISSION ISSUE 15 0.0001
794 VISION BLURRED 7 0.0001
795 DISABILITY 1 0.0001
796 HAEMATOCRIT DECREASED 1 0.0001
797 BLOOD PRESSURE ABNORMAL 1 0.0001
798 COMPLICATION OF DEVICE INSERTION 1 0.0001
799 PRESCRIBED UNDERDOSE 1 0.0001
800 SYNCOPE 5 0.0000
801 FEEDING DISORDER 1 0.0000
802 TASTE DISORDER 1 0.0000
803 WEIGHT INCREASED 11 0.0000
804 BODY TEMPERATURE INCREASED 1 0.0000
805 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
806 PAIN 30 0.0000
807 INFECTION 7 0.0000
808 ASTHENIA 18 0.0000
809 DERMATITIS 1 0.0000
810 DYSPNOEA 27 0.0000
811 PAIN IN EXTREMITY 14 0.0000
812 KNEE ARTHROPLASTY 1 0.0000
813 OSTEOARTHRITIS 2 0.0000
814 JOINT INJURY 1 0.0000
815 IMPAIRED WORK ABILITY 1 0.0000
816 IRRITABLE BOWEL SYNDROME 1 0.0000
817 POOR QUALITY SLEEP 1 0.0000
818 RHINORRHOEA 3 0.0000
819 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
820 VAGINAL HAEMORRHAGE 2 0.0000
821 DEVICE DISLOCATION 2 0.0000
822 PRODUCT DISPENSING ERROR 1 0.0000
823 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
824 MELAENA 1 0.0000
825 APPLICATION SITE PAIN 1 0.0000
826 ANGIOEDEMA 2 0.0000
827 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
828 LIVER DISORDER 2 0.0000
829 TOOTH DISORDER 1 0.0000
830 NEOPLASM MALIGNANT 3 0.0000
831 HYPOTENSION 9 0.0000
832 INFLUENZA 5 0.0000
833 RASH PAPULAR 1 0.0000
834 SNEEZING 1 0.0000
835 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
836 INJECTION SITE REACTION 3 0.0000
837 BACK PAIN 10 0.0000
838 BREAST CANCER 4 0.0000
839 CARDIAC DISORDER 4 0.0000
840 DISEASE RECURRENCE 2 0.0000
841 RENAL CANCER 2 0.0000
842 URTICARIA 7 0.0000
843 BLOOD PRESSURE FLUCTUATION 1 0.0000
844 CONTUSION 4 0.0000
845 JOINT SWELLING 5 0.0000
846 LOCALISED INFECTION 1 0.0000
847 NEURALGIA 1 0.0000
848 INJECTION SITE URTICARIA 1 0.0000
849 OSTEONECROSIS OF JAW 1 0.0000
850 VISUAL IMPAIRMENT 5 0.0000
851 HYPOAESTHESIA 6 0.0000
852 HOT FLUSH 3 0.0000
853 UNEVALUABLE EVENT 3 0.0000
854 ABDOMINAL PAIN LOWER 1 0.0000
855 CARDIOVASCULAR DISORDER 1 0.0000
856 HYPOPHAGIA 1 0.0000
857 THERAPY CESSATION 2 0.0000
858 HAEMATOMA 1 0.0000
859 EXPOSURE VIA SKIN CONTACT 1 0.0000
860 DIPLOPIA 1 0.0000
861 SEDATION 1 0.0000
862 APPLICATION SITE ERYTHEMA 1 0.0000
863 JOINT STIFFNESS 1 0.0000
864 ANHEDONIA 1 0.0000
865 DRUG INTERACTION 6 0.0000
866 EAR INFECTION 1 0.0000
867 DEHYDRATION 5 0.0000
868 CARDIAC FAILURE 3 0.0000
869 JAUNDICE 1 0.0000
870 PAIN OF SKIN 1 0.0000
871 FREQUENT BOWEL MOVEMENTS 1 0.0000
872 RASH PRURITIC 2 0.0000
873 INFLUENZA LIKE ILLNESS 3 0.0000
874 RESPIRATORY ARREST 1 0.0000
875 DIVERTICULITIS 1 0.0000
876 PROCEDURAL PAIN 1 0.0000
877 FEELING COLD 1 0.0000
878 COUGH 10 0.0000
879 OXYGEN SATURATION DECREASED 2 0.0000
880 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
881 INTENTIONAL DOSE OMISSION 1 0.0000
882 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
883 LIVER FUNCTION TEST ABNORMAL 1 0.0000
884 DYSSTASIA 1 0.0000
885 BONE PAIN 2 0.0000
886 ASCITES 1 0.0000
887 WHEEZING 2 0.0000
888 IRRITABILITY 2 0.0000
889 APHASIA 1 0.0000
890 ILL-DEFINED DISORDER 2 0.0000
891 PLEURAL EFFUSION 2 0.0000
892 NASOPHARYNGITIS 6 0.0000
893 HOSPITALISATION 5 0.0000
894 EMOTIONAL DISORDER 1 0.0000
895 SWELLING 3 0.0000
896 HIP FRACTURE 1 0.0000
897 PRODUCT DOSE OMISSION 2 0.0000
898 BLOOD CREATININE INCREASED 2 0.0000
899 CHOLELITHIASIS 1 0.0000
900 EYE DISORDER 1 0.0000
901 FUNGAL INFECTION 1 0.0000
902 SKIN DISORDER 1 0.0000
903 DRY SKIN 4 0.0000
904 RASH 13 0.0000
905 ANGER 1 0.0000
906 HEPATIC ENZYME INCREASED 2 0.0000
907 NIGHTMARE 1 0.0000
908 DELIRIUM 1 0.0000
909 DEVICE USE ERROR 1 0.0000
910 NEOPLASM PROGRESSION 1 0.0000
911 HAEMORRHAGE 3 0.0000
912 RASH MACULAR 1 0.0000
913 HEART RATE DECREASED 1 0.0000
914 DEVICE MALFUNCTION 2 0.0000
915 HYPOXIA 1 0.0000
916 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
917 PLATELET COUNT DECREASED 3 0.0000
918 SKIN BURNING SENSATION 2 0.0000
919 DEATH 24 0.0000
920 CRYING 1 0.0000
921 BRONCHITIS 2 0.0000
922 DYSPNOEA EXERTIONAL 1 0.0000
923 INTESTINAL OBSTRUCTION 1 0.0000
924 COLITIS 1 0.0000
925 GAIT DISTURBANCE 5 0.0000
926 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
927 DECREASED APPETITE 6 0.0000
928 ABNORMAL BEHAVIOUR 1 0.0000
929 CARDIAC FAILURE CONGESTIVE 2 0.0000
930 OEDEMA PERIPHERAL 3 0.0000
931 BLINDNESS 1 0.0000
932 NEUTROPHIL COUNT DECREASED 1 0.0000
933 ERYTHEMA 5 0.0000
934 CARDIAC ARREST 2 0.0000
935 DRUG DOSE OMISSION 4 0.0000
936 INJECTION SITE ERYTHEMA 3 0.0000
937 POLLAKIURIA 1 0.0000
938 CARDIO-RESPIRATORY ARREST 1 0.0000
939 ROAD TRAFFIC ACCIDENT 1 0.0000
940 RENAL FAILURE ACUTE 1 0.0000
941 MENTAL DISORDER 1 0.0000
942 PSORIASIS 3 0.0000
943 INJECTION SITE PAIN 7 0.0000
944 SUICIDAL IDEATION 2 0.0000
945 SKIN IRRITATION 1 0.0000
946 HYPOKALAEMIA 1 0.0000
947 COGNITIVE DISORDER 1 0.0000
948 OCULAR HYPERAEMIA 1 0.0000
949 ANAEMIA 4 0.0000
950 INTERSTITIAL LUNG DISEASE 1 0.0000
951 HYPOGLYCAEMIA 1 0.0000
952 AGGRESSION 1 0.0000
953 FLUSHING 2 0.0000
954 FLUID RETENTION 1 0.0000
955 INFLAMMATION 1 0.0000
956 ECZEMA 1 0.0000
957 DEPRESSED MOOD 1 0.0000
958 PNEUMONIA 6 0.0000
959 ANAPHYLACTIC REACTION 1 0.0000
960 ARTHROPATHY 1 0.0000
961 PANCYTOPENIA 1 0.0000
962 CEREBROVASCULAR ACCIDENT 3 0.0000
963 CONVULSION 1 0.0000
964 LETHARGY 1 0.0000
965 MYOCARDIAL INFARCTION 3 0.0000
966 EMOTIONAL DISTRESS 2 0.0000
967 DISCOMFORT 1 0.0000
968 DEEP VEIN THROMBOSIS 1 0.0000
969 INJECTION SITE PRURITUS 1 0.0000
970 SLEEP DISORDER 1 0.0000
971 THERAPY INTERRUPTED 1 0.0000
972 RESPIRATORY FAILURE 1 0.0000
973 HALLUCINATION 1 0.0000
974 ACNE 1 0.0000
975 INJECTION SITE SWELLING 1 0.0000
976 DRUG DOSE OMISSION BY DEVICE 1 0.0000
977 INJECTION SITE BRUISING 1 0.0000
978 THROMBOSIS 1 0.0000
979 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
980 SKIN EXFOLIATION 1 0.0000
981 PRODUCT STORAGE ERROR 1 0.0000
982 MUSCULOSKELETAL STIFFNESS 1 0.0000
983 DRUG WITHDRAWAL SYNDROME 1 0.0000
984 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
985 DEVICE ISSUE 1 0.0000
986 NO ADVERSE EVENT 2 0.0000
987 PULMONARY EMBOLISM 1 0.0000
988 DRUG INTOLERANCE 1 0.0000
989 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
990 HAEMOGLOBIN DECREASED 1 0.0000
991 THROMBOCYTOPENIA 1 0.0000
992 RHEUMATOID ARTHRITIS 1 0.0000
993 DISEASE PROGRESSION 1 0.0000